Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01154010 · ClinicalTrials.gov registry record · NA
PEMF: an Adjunct Therapy for Anterior Uveitis
A NA study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01154010 is a NA study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 18 participants.
The verdict
NCT01154010, a NA study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a medical device (ActiPatch) that emits a low frequency pulsed electromagnetic field (PEMF) will benefit patients with anterior uveitis. Anterior uveitis (aka iritis) is an inflammatory disease involving the front segment of the eye. This is a common cause of a painful red eye, and ActiPatch has been shown to be effective in treating tissue inflammation. The conventional treatment of iritis typically involves frequent administration of topical steroids which have their own inherent risks (development of cataracts and/or glaucoma). The purpose of this study is to determine if ActiPatch therapy can be used to shorten the length of time and/or quantity of steroids administered.
Interventions
- DEVICE PEMF
- DEVICE PEMF Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2009-08 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01154010
The ClinicalTrials.gov registry entry for NCT01154010 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PEMF is the first listed.
NCT01154010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01154010 about?
NCT01154010 is a clinical study titled "PEMF: an Adjunct Therapy for Anterior Uveitis". The purpose of this study is to determine if a medical device (ActiPatch) that emits a low frequency pulsed electromagnetic field (PEMF) will benefit patients with anterior uveitis. Anterior uveitis (aka iritis) is an inflammatory disease involving the front segment of the eye. This is a common caus...
What is the current status of trial NCT01154010?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2009-08. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01154010?
The interventions under investigation include: PEMF (DEVICE), PEMF Placebo (DEVICE).
Who is sponsoring clinical trial NCT01154010?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.